Document is current
Any future updates will be listed below
-
Authors
Herrera-Rivero, Marisol
Adli, Mazda
Akiyama, Kazufumi
Akula, Nirmala
Amare, Azmeraw T.
Ardau, Raffaella
Arias, Bárbara
Aubry, Jean-Michel
Backlund, Lena
Bellivier, Frank
Benabarre, Antonio
Bengesser, Susanne
Bhattacharjee, Abesh Kumar
Biernacka, Joanna M.
Birner, Armin
Cearns, Micah
Cervantes, Pablo
Chen, Hsi-Chung
Chillotti, Caterina
Cichon, Sven
Clark, Scott R.
Colom, Francesc
Cruceanu, Cristiana
Czerski, Piotr M.
Dalkner, Nina
Degenhardt, Franziska
Del Zompo, Maria
DePaulo, J. Raymond
Etain, Bruno
Falkai, Peter
Ferensztajn-Rochowiak, Ewa
Forstner, Andreas J.
Frank, Josef
Frisén, Louise
Frye, Mark A.
Fullerton, Janice M.
Gallo, Carla
Gard, Sébastien
Garnham, Julie S.
Goes, Fernando S.
Grigoroiu-Serbanescu, Maria
Grof, Paul
Hashimoto, Ryota
Hasler, Roland
Hauser, Joanna
Heilbronner, Urs
Herms, Stefan
Hoffmann, Per
Hou, Liping
Hsu, Yi-Hsiang
Jamain, Stephane
Jiménez, Esther
Kahn, Jean-Pierre
Kassem, Layla
Kato, Tadafumi
Kelsoe, John
Kittel-Schneider, Sarah
Kuo, Po-Hsiu
Kusumi, Ichiro
König, Barbara
Laje, Gonzalo
Landén, Mikael
Lavebratt, Catharina
Leboyer, Marion
Leckband, Susan G.
Maj, Mario
Manchia, Mirko
Marie-Claire, Cynthia
Martinsson, Lina
McCarthy, Michael J.
McElroy, Susan L.
Millischer, Vincent
Mitjans, Marina
Mondimore, Francis M.
Monteleone, Palmiero
Nievergelt, Caroline M.
Novák, Tomas
Nöthen, Markus M.
O’Donovan, Claire
Ozaki, Norio
Papiol, Sergi
Pfennig, Andrea
Pisanu, Claudia
Potash, James B.
Reif, Andreas
Reininghaus, Eva
Richard-Lepouriel, Hélène
Roberts, Gloria
Rouleau, Guy A.
Rybakowski, Janusz K.
Schalling, Martin
Schofield, Peter R.
Schubert, Klaus Oliver
Schulte, Eva C.
Schweizer, Barbara W.
Severino, Giovanni
Shekhtman, Tatyana
Shilling, Paul D.
Shimoda, Katzutaka
Simhandl, Christian
Slaney, Claire M.
Squassina, Alessio
Stamm, Thomas
Stopkova, Pavla
Streit, Fabian
Tekola-Ayele, Fasil
Thalamuthu, Anbupalam
Tortorella, Alfonso
Turecki, Gustavo
Veeh, Julia
Vieta, Eduard
Viswanath, Biju
Witt, Stephanie H.
Zandi, Peter P.
Alda, Martin
Bauer, Michael
McMahon, Francis J.
Mitchell, Philip B.
Rietschel, Marcella
Schulze, Thomas G.
Baune, Bernhard T.
-
Funding
Funding for this research was provided by:
Universität Münster
- License Information
-
More Information
Article History
Received: 28 November 2023
Accepted: 2 May 2024
First Online: 12 June 2024
Declarations
:
: The Ethics Committee at the University of Heidelberg provided central approval for ConLiGen. Written informed consent from all participants was obtained according to the study protocols of each of the participating sites and their institutions. All procedures were performed in accordance with the guidelines of the Declaration of Helsinki.
: Not applicable.
: Eduard Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbvie, Almirall, Allergan, Angelini, AstraZeneca, Bristol-Myers Squibb, Dainippon Sumitomo Pharma, Farmindustria, Ferrer, Forest Research Institute, Gedeon Richter, GH Research, Glaxo-Smith-Kline, Janssen, Lundbeck, Orion, Otsuka, Pfizer, Roche, Rovi, Sanofi-Aventis, Servier, Shire, Sunovion, Takeda, the Brain and Behaviour Foundation, the Spanish Ministry of Science and Innovation (CIBERSAM), the Stanley Medical Research Institute and Viatris. Michael Bauer has received grants from the Deutsche Forschungsgemeinschaft (DFG), and Bundesministeriums für Bildung und Forschung (BMBF), and served as consultant, advisor or CME speaker for the following entities: Allergan, Aristo, Janssen, Lilly, Lundbeck, neuraxpharm, Otsuka, Sandoz, Servier and Sunovion outside the submitted work. Sarah Kittel-Schneider has received grants and served as consultant, advisor or speaker for the following entities: Medice Arzneimittel Pütter GmbH and Takeda. Bernhard Baune has received grants and served as consultant, advisor or CME speaker for the following entities: AstraZeneca, Bristol-Myers Squibb, Janssen, Lundbeck, Otsuka, Servier, the National Health and Medical Research Council, the Fay Fuller Foundation, the James and Diana Ramsay Foundation. Tadafumi Kato received honoraria for lectures, manuscripts, and/or consultancy, from Kyowa Hakko Kirin Co, Ltd, Eli Lilly Japan K.K., Otsuka Pharmaceutical Co, Ltd, GlaxoSmithKline K.K., Taisho Toyama Pharmaceutical Co, Ltd, Dainippon Sumitomo Pharma Co, Ltd, Meiji Seika Pharma Co, Ltd, Pfizer Japan Inc., Mochida Pharmaceutical Co, Ltd, Shionogi & Co, Ltd, Janssen Pharmaceutical K.K., Janssen Asia Pacific, Yoshitomiyakuhin, Astellas Pharma Inc, Wako Pure Chemical Industries, Ltd, Wiley Publishing Japan, Nippon Boehringer Ingelheim Co Ltd, Kanae Foundation for the Promotion of Medical Science, MSD K.K., Kyowa Pharmaceutical Industry Co, Ltd and Takeda Pharmaceutical Co, Ltd. Tadafumi Kato also received a research grant from Takeda Pharmaceutical Co, Ltd. Peter Falkai has received grants and served as consultant, advisor or CME speaker for the following entities Abbott, GlaxoSmithKline, Janssen, Essex, Lundbeck, Otsuka, Gedeon Richter, Servier and Takeda as well as the German Ministry of Science and the German Ministry of Health. Eva Reininghaus has received grants and served as consultant, advisor or CME speaker for the following entities: Janssen and Institut Allergosan. Mikael Landén has received lecture honoraria from Lundbeck. Kazufumi Akiyama has received consulting honoraria from Taisho Toyama Pharmaceutical Co, Ltd. Scott Clark has received grants, or data and served as consultant, advisor or CME speaker for the following entities: Otsuka Austalia, Lundbeck Australia, Janssen-Cilag Australia, Servier Australia,Viatris. Bruno Etain received honoraria from Sanofi Aventis. The rest of authors have no conflicts of interest to disclose.
